143 related articles for article (PubMed ID: 38700366)
1. Radiological Features for Predicting the Status of CD8-Positive Lymphocytes in HER2 Positive Breast Cancer.
Fan Y; Li X; Zhong P; Guo H; Han D; Tian W; Fang J
Balkan Med J; 2024 May; 41(3):213-221. PubMed ID: 38700366
[TBL] [Abstract][Full Text] [Related]
2. HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes.
Lee HJ; Lee JE; Jeong WG; Ki SY; Park MH; Lee JS; Nah YK; Lim HS
AJR Am J Roentgenol; 2022 Feb; 218(2):258-269. PubMed ID: 34431365
[No Abstract] [Full Text] [Related]
3. Correlation between apparent diffusion coefficient of magnetic resonance imaging and tumor-infiltrating lymphocytes in breast cancer.
Fogante M; Tagliati C; De Lisa M; Berardi R; Giuseppetti GM; Giovagnoni A
Radiol Med; 2019 Jul; 124(7):581-587. PubMed ID: 30806920
[TBL] [Abstract][Full Text] [Related]
4. Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer.
Fukui K; Masumoto N; Shiroma N; Kanou A; Sasada S; Emi A; Kadoya T; Yokozaki M; Arihiro K; Okada M
Breast Cancer; 2019 Sep; 26(5):573-580. PubMed ID: 30868399
[TBL] [Abstract][Full Text] [Related]
5. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of imaging findings in predicting tumor-infiltrating lymphocytes in patients with breast cancer.
Çelebi F; Agacayak F; Ozturk A; Ilgun S; Ucuncu M; Iyigun ZE; Ordu Ç; Pilanci KN; Alco G; Gultekin S; Cindil E; Soybir G; Aktepe F; Özmen V
Eur Radiol; 2020 Apr; 30(4):2049-2057. PubMed ID: 31822972
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-Based Radiomics.
Bian T; Wu Z; Lin Q; Mao Y; Wang H; Chen J; Chen Q; Fu G; Cui C; Su X
J Magn Reson Imaging; 2022 Mar; 55(3):772-784. PubMed ID: 34453461
[TBL] [Abstract][Full Text] [Related]
8. Correlation between
Murakami W; Tozaki M; Sasaki M; Hida AI; Ohi Y; Kubota K; Sagara Y
Eur J Radiol; 2020 Feb; 123():108773. PubMed ID: 31918248
[TBL] [Abstract][Full Text] [Related]
9. CD8(+) tumor-infiltrating lymphocytes contribute to spontaneous "healing" in HER2-positive ductal carcinoma in situ.
Morita M; Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Kanomata N; Naito Y; Akiba J; Hattori S; Minami S; Eguchi S; Yano H
Cancer Med; 2016 Jul; 5(7):1607-18. PubMed ID: 27061242
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
[No Abstract] [Full Text] [Related]
11. A simple and convenient model combining multiparametric MRI and clinical features to predict tumour-infiltrating lymphocytes in breast cancer.
Chen S; Sui Y; Ding S; Chen C; Liu C; Zhong Z; Liang Y; Kong Q; Tang W; Guo Y
Clin Radiol; 2023 Dec; 78(12):e1065-e1074. PubMed ID: 37813758
[TBL] [Abstract][Full Text] [Related]
12. Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Liu S; Chen B; Burugu S; Leung S; Gao D; Virk S; Kos Z; Parulekar WR; Shepherd L; Gelmon KA; Nielsen TO
JAMA Oncol; 2017 Nov; 3(11):e172085. PubMed ID: 28750133
[TBL] [Abstract][Full Text] [Related]
13. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
[TBL] [Abstract][Full Text] [Related]
14. Problem Solving MRI to Reduce False-Positive Biopsy Related to Breast US: Conductivity vs. DWI vs. Abbreviated Contrast-Enhanced MRI.
Kim JH; Kim SY; Cui C; Ji H; Yoen H; Cho N; Kim DH
J Magn Reson Imaging; 2024 Apr; 59(4):1218-1228. PubMed ID: 37477575
[TBL] [Abstract][Full Text] [Related]
15. Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer.
Abe N; Matsumoto H; Takamatsu R; Tamaki K; Takigami N; Uehara K; Kamada Y; Tamaki N; Motonari T; Unesoko M; Nakada N; Zaha H; Yoshimi N
Virchows Arch; 2020 May; 476(5):701-709. PubMed ID: 31873876
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma.
Chen P; Zhao S; Guo W; Shao G
Quant Imaging Med Surg; 2023 Aug; 13(8):4816-4825. PubMed ID: 37581065
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Tumor Infiltrating Lymphocytes in Locally Advanced HER2 Enriched Breast Cancer.
Saber MM; El Zawahry HM; Hilal AM; Abou-Bakr AA; Namour AE; Saber MM
Asian Pac J Cancer Prev; 2022 Feb; 23(2):553-560. PubMed ID: 35225468
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.
Jääskeläinen MM; Tiainen S; Siiskonen H; Ahtiainen M; Kuopio T; Rönkä A; Kettunen T; Hämäläinen K; Rilla K; Harvima I; Mannermaa A; Auvinen P
Breast Cancer Res Treat; 2023 Sep; 201(2):183-192. PubMed ID: 37428418
[TBL] [Abstract][Full Text] [Related]
19. Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
Lundgren C; Bendahl PO; Ekholm M; Fernö M; Forsare C; Krüger U; Nordenskjöld B; Stål O; Rydén L
Breast Cancer Res; 2020 Dec; 22(1):140. PubMed ID: 33357231
[TBL] [Abstract][Full Text] [Related]
20. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]